China Looks Ahead on AI Medtech With New Guidelines, Collaboration

article image

Getting new artificial intelligence technologies through China regulators is by no means going to be easy, but the National Medical Products Administration is working with other experts in the country to lay a policy groundwork for the sector, including recently finalized guidelines for “deep learning” AI devices.

China is taking steps to fill gaps in its regulatory framework for AI-based medical technology.


This article is restricted to subscribers only.

Sign in to continue reading.


We're here to help! Please contact us at: